PL208292B1 - Przeciwciało, zastosowanie przeciwciała, sposób jego wytwarzania, zestaw do diagnozowania i linia komórkowa hybrydoma - Google Patents

Przeciwciało, zastosowanie przeciwciała, sposób jego wytwarzania, zestaw do diagnozowania i linia komórkowa hybrydoma

Info

Publication number
PL208292B1
PL208292B1 PL360139A PL36013901A PL208292B1 PL 208292 B1 PL208292 B1 PL 208292B1 PL 360139 A PL360139 A PL 360139A PL 36013901 A PL36013901 A PL 36013901A PL 208292 B1 PL208292 B1 PL 208292B1
Authority
PL
Poland
Prior art keywords
tyr
gln
antibody
glu
prp
Prior art date
Application number
PL360139A
Other languages
English (en)
Polish (pl)
Other versions
PL360139A1 (en
Inventor
Vladka Čurin-Šerbec
Original Assignee
Blood Transfusion Ct Of Slovenia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL208292(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blood Transfusion Ct Of Slovenia filed Critical Blood Transfusion Ct Of Slovenia
Publication of PL360139A1 publication Critical patent/PL360139A1/xx
Publication of PL208292B1 publication Critical patent/PL208292B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL360139A 2000-05-23 2001-05-15 Przeciwciało, zastosowanie przeciwciała, sposób jego wytwarzania, zestaw do diagnozowania i linia komórkowa hybrydoma PL208292B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111108A EP1158003B2 (en) 2000-05-23 2000-05-23 Antibodies capable to selectively detect prion PrP Sc isoforms
PCT/IB2001/001666 WO2001090191A2 (en) 2000-05-23 2001-05-15 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS

Publications (2)

Publication Number Publication Date
PL360139A1 PL360139A1 (en) 2004-09-06
PL208292B1 true PL208292B1 (pl) 2011-04-29

Family

ID=8168816

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360139A PL208292B1 (pl) 2000-05-23 2001-05-15 Przeciwciało, zastosowanie przeciwciała, sposób jego wytwarzania, zestaw do diagnozowania i linia komórkowa hybrydoma

Country Status (14)

Country Link
EP (1) EP1158003B2 (https=)
JP (1) JP5042430B2 (https=)
KR (1) KR100829447B1 (https=)
CN (1) CN1250572C (https=)
AR (1) AR029098A1 (https=)
AT (1) ATE312848T1 (https=)
AU (2) AU2001284355B2 (https=)
CA (1) CA2407905C (https=)
DE (1) DE60024787T3 (https=)
DK (1) DK1158003T4 (https=)
ES (1) ES2253156T5 (https=)
HU (1) HU229454B1 (https=)
PL (1) PL208292B1 (https=)
WO (1) WO2001090191A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059386A2 (en) * 2002-01-18 2003-07-24 Cytos Biotechnology Ag Prion protein carrier-conjugates
EP1596199A1 (en) * 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion
JP4246777B1 (ja) * 2007-11-20 2009-04-02 森永乳業株式会社 異常型プリオン蛋白質結合剤および異常型プリオン蛋白質の検出方法
EP2135880A1 (en) * 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
AU2009301580B2 (en) 2008-10-06 2015-11-26 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ246059A (en) * 1991-12-03 1995-08-28 Proteus Molecular Design Synthetic polypeptides with at least one antigenic site of a prion protein, methods of their use and manufacture, antibodies thereto, compositions and kits
DE852011T1 (de) * 1995-09-14 2001-10-11 Scripps Res Inst La Jolla Für natives prp-sc spezifische antikörper
EP0861900A1 (en) † 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen

Also Published As

Publication number Publication date
ES2253156T5 (es) 2013-04-30
DE60024787T3 (de) 2013-06-06
CN1441811A (zh) 2003-09-10
AU8435501A (en) 2001-12-03
AU2001284355B2 (en) 2005-11-10
EP1158003B2 (en) 2012-12-26
EP1158003A1 (en) 2001-11-28
HUP0302413A2 (hu) 2003-10-28
HU229454B1 (en) 2013-12-30
WO2001090191A3 (en) 2002-06-20
ATE312848T1 (de) 2005-12-15
EP1158003B1 (en) 2005-12-14
PL360139A1 (en) 2004-09-06
WO2001090191A2 (en) 2001-11-29
ES2253156T3 (es) 2006-06-01
JP2003534000A (ja) 2003-11-18
DK1158003T4 (da) 2013-04-08
KR20030014234A (ko) 2003-02-15
KR100829447B1 (ko) 2008-05-15
CA2407905A1 (en) 2001-11-29
DK1158003T3 (da) 2006-05-01
JP5042430B2 (ja) 2012-10-03
DE60024787T2 (de) 2006-09-07
CN1250572C (zh) 2006-04-12
CA2407905C (en) 2012-08-14
AR029098A1 (es) 2003-06-04
DE60024787D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
EP1194164B1 (en) Prion protein peptides and uses thereof
KR101434935B1 (ko) 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의용도
CN101367875B (zh) N-11端截短的β-淀粉样蛋白的单克隆抗体、组合物、方法和用途
EP0809656B1 (en) MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE
US20120107321A1 (en) Antibodies And Epitopes Specific To Misfolded Prion Protein
AU6492794A (en) Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US7041807B1 (en) Antibodies to a YYX epitope of a mammalian prion protein
CA2407905C (en) Antibodies capable to selectively detect prion prpsc isoforms
US20070281318A1 (en) Use of monoclonal antibodies to distinguish protein conformational isoforms
US7098317B1 (en) Antibodies capable to selectively detect prion PrPSc isoforms
WO2002046236A1 (fr) Anticorps monoclonal dirigé contre un prion anormal, procédé de production correspondant, et procédé d'essai immunologique l'utilisant
AU2019246844A1 (en) Monoclonal antibodies against amyloid beta protein and uses thereof

Legal Events

Date Code Title Description
RECP Rectifications of patent specification